ADRO - Aduro Biotech, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ADRO (1435049)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
41 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S41-1-2-10-36

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-04-03
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$10.71-8,00049,300-14%-$85,645-3-3
D
2017-04-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.28-27,273172,857-14%-$280,429-3-3
D
2017-03-13
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.35-27,273172,857-14%-$309,434+3+5-14
D
2017-03-09
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.00-8,00049,300-14%-$88,00100-23
D
2017-03-09
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$10.96-25,00039,900-39%-$274,07800-23
D
2017-01-17
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.86-8,00049,300-14%-$94,858+1+1+4
2017-01-11
ADROTempleman BlaineEVP, GCS - Sale$11.95-3,78537,300-9%-$45,231-4-10-13
D
2017-01-03
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.16-25,00039,900-39%-$278,990-2-10
D
2017-01-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.12-27,273172,857-14%-$303,289-2-10
D
2016-12-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.82-27,273223,857-11%-$295,169+4+2+4
D
2016-12-01
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$10.94-25,00039,900-39%-$273,500+4+2+4
2016-11-14
ADROHaghighat RossDirS - Sale$15.50-7,08881,880-8%-$109,864+1+1-18
D
2016-11-14
ADROIsaacs Stephen TPres, CEOS - Sale+OE$15.26-27,273223,857-11%-$416,050+1+1-18
D
2016-11-10
ADROLew JenniferSVP of FinanceS - Sale+OE$14.95-10,91042,595-20%-$163,105-6-8-27
DM
2016-11-10
ADROSchafer Gregory WCOOS - Sale+OE$14.78-80,00085,979-48%-$1,182,731-6-8-27
D
2016-11-10
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$14.78-25,00039,900-39%-$369,408-6-8-27
D
2016-10-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$12.67-27,273223,857-11%-$345,522-6-6-22-33
D
2016-10-03
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$12.68-25,00039,900-39%-$316,908-6-6-22-33
D
2016-09-19
ADROLew JenniferSVP of FinanceS - Sale+OE$14.95-6,36042,595-13%-$95,082+1-7-23-28
D
2016-09-01
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$14.03-25,0000-100%-$350,775+7-4-12-25
D
2016-08-11
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$15.18-25,0000-100%-$379,500+3-3-9-30
D
2016-07-05
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.61-25,0000-100%-$290,250+20+23-4
2016-05-16
ADROBrockstedt Dirk G.SVP of Research, Dev.S - Sale$8.20-90512,000-7%-$7,421-3+8+16+52
2016-05-16
ADROSchafer Gregory WCOOS - Sale$8.20-90549,279-2%-$7,421-3+8+16+52
2016-05-16
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale$8.20-9050-100%-$7,421-3+8+16+52
D
2016-01-11
ADROBrockstedt Dirk G.SVP of Research, Dev.S - Sale+OE$21.77-22,00012,000-65%-$479,015+2-7-39-40
D
2016-01-08
ADROSchafer Gregory WCOOS - Sale+OE$23.58-20,00049,279-29%-$471,600+2-7-39-40
D
2016-01-04
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$26.37-15,0000-100%-$395,531-4-8-35-48
DM
2016-01-04
ADROIsaacs Stephen TPres, CEOS - Sale+OE$26.31-25,000166,157-13%-$657,799-4-8-35-48
D
2016-01-06
ADROLew JenniferSVP of FinanceS - Sale+OE$25.71-5,2426,200-46%-$134,765-4-8-35-48
D
2015-12-10
ADROBrockstedt Dirk G.SVP of Research, Dev.S - Sale+OE$29.82-25,0000-100%-$745,4230-6-34-65
D
2015-12-07
ADROSchafer Gregory WCOOS - Sale+OE$29.74-25,00034,279-42%-$743,571+5+1-16-58
D
2015-12-03
ADROLew JenniferSVP of FinanceS - Sale+OE$29.85-5,2422,000-72%-$156,486+5+1-16-58
D
2015-12-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$29.11-25,000156,157-14%-$727,6640+5-5-59
D
2015-12-01
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$29.27-30,0000-100%-$878,1040+5-5-59
2015-11-30
ADROGreenman William MarinerDirS - Sale$30.65-3,0000-100%-$91,9500+5-5-59
D
2015-11-18
ADROLew JenniferSVP of FinanceS - Sale+OE$28.52-6,7122,000-77%-$191,426-1-6+10-65
D
2015-11-16
ADROIsaacs Stephen TPres, CEOS - Sale+OE$27.54-25,000156,157-14%-$688,490-1-6+10-65
DM
2015-11-16
ADROBrockstedt Dirk G.SVP of Research, Dev.S - Sale+OE$28.34-26,4700-100%-$750,028-1-6+10-65
DM
2015-11-16
ADROSchafer Gregory WCOOS - Sale+OE$28.15-26,47034,279-44%-$745,241-1-6+10-65
DM
2015-11-16
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$28.27-31,4700-100%-$889,556-1-6+10-65

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top